Stem Cell therapies are in their infancy and will continue to grow in popularity not only among the general public but also among the medical community.
A report by Robin Young and the New York Stem Cell Summit ‘16 indicates that stem cell therapies are set for explosive growth both in the US and internationally.
Reintroduction of cultivated stem cells must be done outside of the United States hence the importance of international Stem Cell processing center.
Stem Cell processing center will allow the client to conduct research and perform highly advanced stem cell procedures. The project represents a self-reinforcing vertical enterprise.
The market should realize a dramatic in increase of revenue during the next eight years and reach a size of 6.04 billion dollars in the US alone.
Client could exit in 3-5 years by being acquired by strategic company that does not have the breadth of stem cell services internally.